Hematopoietic stem cells (HSCs) are believed t o play a critical role in the sustained repopulation of all blood cells after bone marrow transplantation (BMT). However, understanding the role of HSCs versus other hematopoietic cells in the quantitative reconstitution of various blood cell types has awaited methods t o isolate HSCs. A candidate population of mouse HSCs, Thy-1.1'" Lin-Sca-l+ cells, was isolated several years ago and, recently, this population has been shown t o be the only population of BM cells that contains HSCs in C57BL/Ka-Thy-l.l mice. As few as 100 of these cells can radioprotect 95% t o 100% of irradiated mice, resulting longterm multilineage reconstitution. In this study, we examined the reconstitution potential of irradiated mice transplanted with purified Thy-1.1'" Lin-Sca-l+ BM cells. Donor-derived peripheral blood (PB) white blood cells were detected as early as day 9 or 10 when 100 t o 1.000 Thy-1.1'" Lin-Sca-l+ cells were used, with minor dose-dependent differences. The reappearance of platelets by day 14 and thereafter was also seen at all HSC doses (100 t o 1,000 cells), with a slight dosedependence. All studied HSC doses also allowed RBC levels to recover, although at the 100 cell dose a delay in hemato-ONE MARROW transplantation (BMT) is an effective therapy' for various nonmalignant and malignant hematologic diseases, including genetic disorders and immunodefi~iencies.*-~ Despite recent advances in BMT, there remains a number of barriers to its widespread application. For example, autologous BMT for malignancies may be complicated by the presence of malignant cells in the inoculum; and allogeneic BMT may be compromised by the inclusion of alloreactive T cells, leading to graft-versus-host disease (GVHD).6,7
ONE MARROW transplantation (BMT) is an effective
therapy' for various nonmalignant and malignant hematologic diseases, including genetic disorders and immunodefi~iencies.*-~ Despite recent advances in BMT, there remains a number of barriers to its widespread application. For example, autologous BMT for malignancies may be complicated by the presence of malignant cells in the inoculum; and allogeneic BMT may be compromised by the inclusion of alloreactive T cells, leading to graft-versus-host disease (GVHD). 6, 7 Hematopoietic stem cells (HSCs) are responsible for the sustained production of all blood cell components after BMT. Isolation of highly purified HSCs should be free of malignant cells and T cells, and therefore could be effective at improving BMT as a therapeutic tool.' However, it is unclear whether HSCs can also contribute significantly to the early hematopoietic recovery of critical blood components ablated by radiation and chemotherapy, because mature blood cells and immature progenitors are likely to be major contributors also, at least in the early phases.
Mouse HSCs can be enriched by different technique^?"^ and can be transplanted to large numbers of syngeneic, con-crit recovery was observed at day 14. When irradiated mice were transplanted with 500 Thy-l.lb Lin-Sca-l+ cells compared with 1 x lo6 BM cells (the equivalent amount of cells that contain 500 Thy-1.1" Lin-Sca-l+ cells as well as progenitor and mature cells). very r i l e difference in the kinetics of recovery of PB, white blood cells, platelets, and hematocrit was observed. Surprisingly, even when 200 Thy-1.1'" LinSca-l+ cells were mixed with 4 x lo5 Sca-l-BM cells in a competitive repopulation assay, most of the early (days 11 and 14) PB myeloid cells were derived from the HSC genotype, indicating the superiority of the Thy-1.1'" Lin-Sea-l+ cells over Sca-l-cells even in the early phases of myeloid reconstitution. Within the Thy-1.1'" Lin-Sca-l+ population, the Rhodamine 123 (Rh123Ihi subset dominates in PB myeloid reconstitution at 10 t o 14 days, only t o be overtaken by the Rh123'" subset at 3 weeks and thereafter. These findings indicate that HSCs can account for the early phase of hematopoietic recovery, as well as sustained hematopoiesis, and raise questions about the role of non-HSC BM populations in the setting of BMT.
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genic, andor allogeneic ani mal^.'^,'^ We have isolated a population of BM Thy-1.1'" Lin-Sca-I' cells that represent -0.05% of BM cells, and are -2,000-fold enriched for HSC activity in radioprotection assays.'* These cells are also enriched as in the following assays: clonogenic precursors of T, B, and myeloerythroid lineages, self-renewal; and longterm multilineage reconstitution.'*.*" As few as 25 to 30 of these cells radioprotect 50% of irradiated hosts, and 100 cells can radioprotect 95% to 100% of lethally irradiated mice; such mice show long-term multilineage donor-derived reconstitution. No HSCs or pre-HSCs can be found in C57BLIThy-1.1 adult BM population other than the Thy-1.1 lo Lin-Sca-l + cells.2' That is not to say that this population is homogeneous: limit-dilution in vivo reconstitutions always led to myeloerythroid and lymphoid components derived from a single clonogenic unit, but the productive lifespan of a clone (as assayed by the continuous production of the short-lived myelomonocytic cells) varied from several weeks to 1 to 2 years, the lifespan of a mouse." This functional heterogeneity is reflected in considerable phenotypic heterogeneity in terms of Rh123 ~t a i n i n g ,~~~~~ cell cycle stat u~,~~ cell size," and low level expression of selected Lin markers (Wineman et a1,2s Onishi et a1, 26 Morrison and Weissman, manuscript in preparation). Although these heterogeneous HSCs might contribute differentially to the reconstitution of irradiated hosts, they do not contain either mature cells or, to our knowledge, oligo-or single-lineage committed progenitors.
Therefore, in the mouse, one could use the Thy-l . l'" Lin Sca-l+ cell population to determine the role of HSCs in reconstitution of blood cells as compared with whole BM. In this study, we compared the kinetics of hematopoietic recovery using purified Thy-1.1 l" Lin-Sca-1
Thy-l. 1 I" Lin-Sca-1 + cells, with only a brief lag in comparison to BM cells. Since submission of this report, a similar study by Okada et a1" have reported results showing that Lin-c-kit' Rh123'" cells, about IO-fold less enriched for radioprotective cells than Thy-l .l'" Lin-Sca-l+ cells, also give rise to early appearing myelomonocytic and B-lineage blood cells.
MATERIALS AND METHODS
Mouse .wains. The C57BU6 (Thy-1.2, Ly-5.2). C57BL1Ka (Thy-I .2, Ly-5.2). C57BW6J-Ly-5. 1 -Pep'h (Thy-l .2, Ly-5. I). C57BWKa-Thy-l . 1 (Thy-I . I , Ly-5.2). and CS7BL1Ka-Thy-1. I -Ly-5.1 (Thy-l .l, Ly-5.1) congenic mouse strains (Ly-5 nomenclature defined in Morse et al'"; see Table 2 ) used in the study were bred and maintained in the mouse facility at Stanford University. All mice were regularly maintained on acidified water (pH 2.5).
Purificarion of Thy-l"' Lin-Sco-l' cells. BM cells were obtained by flushing tibias and femurs. Thy-1.1'" Lin-Sca-l+ cells were stained and isolated from BM as described previously.'x The following lineage marker antibodies were used: RA3-6B2 for the Blineage marker 8220; for T-cell markers, CD4 (GK1.5) and CD8 (53.6.72); for myelomonocytic markers. GR-I (RB6-8CS) and Mac-I (M1170.15.1 IS); and forerythrocytes,TER-I 19 (Kinaet al. manuscript, in preparation). In some experiments, antibodies for NKI.1 (PK136; PharMingen, San Diego, CA) and CD5 (53.7.3) were also included for lineage markers. Antibodies used for positive selection were 19XES (Thy-l . l ) and Sca-l (Ly-6E). The cells were incubated for 20 minutes on ice for each step, followed by a wash through a fetal calf serum cushion. After the final wash, cells were resuspended in Hanks' Balanced Salt Solution (HBSS) containing 1 pg1mL propidium iodide. The labeled cells were analyzed and sorted with a dual-laser FACS (Becton Dickinson lmmunocytometry Systems, Mountain View, CA), modified as described'" and made available through the FACS shared user group at Stanford University. Dead cells were excluded from analysis by their propidium iodide staining characteristics. After sorting, the purity of Thy-1.1'" Lin-Sca-1'. cells was checked by reanalysis by FACS. For convenience, the Lin-"" subset will be called Lin-hereafter, although it includes CD4'" and Mac-l'" cells (Momson and Weissman, manuscript in preparation).
HSCs and RMT. Recipient mice were lethally irradiated by a 250-kV X-ray machine in two split doses with a 3-hour interval. Later the same day, sorted Thy-l .l'" Lin-Sca-l+ cells or BM cells were injected (200 pL per mouse) intravenously into the retroorbital plexus. After irradiation, mice were maintained on antibiotic water containing IOh U/L of polymyxin B sulfate and 1 . l g/L of neomycin sulfate.
Peripheral blood (PR) cells and BM analysis. Experimental animals were analyzed 7 to 28 days after BMT. PB was obtained (250 pL per mouse) from the retroorbital sinus. Two to four mice from each group were used, and same mouse was bled at only one time point in most cases. White blood cell (WBC) counts, platelet counts, and hematocrits were determined by CELL-DYN 1600 (SequoiaTurner, Mountain View, CA), and were confirmed manually with the use of Unopette (Becton Dickinson, Rutherford, NJ).
The significance of differences of hematopoietic recovery between different doses of HSCs transplanted was determined by the twotailed f-test using the StatView I1 (Abacus Concepts, Berkeley, CA) on a Macintosh llcx (Apple Computer, Cupertino, CA), and in some cases by x ' analysis. PB leukocytes (PBLs) were analyzed after immunofluorescence staining and FACS analysis were performed as described previously.'" Two-color staining was performed with the above mentioned lineage markers. Allelic markers for donorhost T (anti-Thy- Femurs from experimental mice were fixed with formalin, decalcified, paraffin-sectioned. and stained with hematoxylin and eosin for histologic study. The defined gates give the limits of Thy-l.l'", of Lin-(which includes Lin'"), and of Sca-l'; in this reanalysis and all sorts used for these experiments, greater than 90% of reanalyzed cells were within these gates.
RESULTS

PuriJied
Hematopoietic loss in lethally irradiated mice. We determined the WBC count, platelet count, and hematocrit to monitor hematologic changes in lethally irradiated mice. Two different congenic mouse strains were tested for hematologic loss after lethal irradiation. CS7BL/6-Ly-5. I mice were irradiated at 8.5 Gy (Fig 2B, shaded lines) and C57BW Ka mice were irradiated at 8.8 Gy (Fig 2C, shaded lines) . Irradiated mice that did not receive any cells died 7 to 14 days after the irradiation because of hematopoietic failure. The WBC count showed a sharp decrease by day I after irradiation, from 6 to 7 X 10' cells/pL to levels of less than I X 10' cells/pL. On the other hand, platelet counts stayed relatively high for 3 days (900 to 1,200 X I03/pL) after irradiation, followed by a rapid decline S to 7 days after irradiation to less than 1 0 0 X 1OZ/pL. Strain differences were observed for the decline of hematocrit. The hematocrit decreased constantly from 43% to 29% at day 12 (1.1% decline per day) for CS7BWKa mice, and from 44% to 6% (2.7% decline per day) at day 14 for CS7BW6-Ly-5.1 mice, although CS7BWKa mice were irradiated at a slightly higher dose. It shall be of interest to test whether red blood cell (RBC) lifespan in these two strains of mice differ in a genetically related fashion. (Figs 2 and 3) . Recovery of PB WBC levels greater than irradiation controls was not seen at day 7 with these cells, but was clearly above background at the next interval tested, day 14, and thereafter. In two of three experiments, hosts receiving 100 cells had lower The normal values of WBC counts, platelet counts, and percentages of hematocrit of unirradiated mice are represented (shaded box). Although the intended dose of irradiation in experiment 1 was 8.5 Gy, mice were irradiated at 7.8 Gy because of an x-ray machine calibration error. However, they were reconstituted with donorderived cells (Figs 4 and 5) .
WBC counts than hosts receiving 500 or 1,000 cells on day 14, but not thereafter (Fig 2) . At no time point did hosts receiving 1,000 cells have higher WBC counts than hosts receiving 500 cells. Therefore, 500 cells appears to be the "saturating dose" of HSCs as measured by WBC counts. At day 28, the WBC levels in the recipient mice had increased to 1 to 3 X 10' cells/pL for all Thy-1.1'" Lin-Sca-l' cell doses.
The nadir of platelet counts occurred at day 7 in irradiated mice reconstituted with 1,000 Thy-1.1 l" Lin-Sca-1 ' cells (Fig 2) . By day IO to 14 (and thereafter), the platelet counts receiving doses of Thy-l . l lo Lin-Sca-1 ' cell transplants (Fig   2) . In all three experiments, the platelet counts at day 14 were directly correlated with the input Thy-l .l'" Lin-Sca-1 + cell number, but in two of three experiments at day 21, mice receiving 100 cells had much higher platelet counts than mice receiving 500 cells. Thus, in mice receiving Thy-I . 1'" Lin-Sca-l+ cell transplants of IO0 to I,WO cells, a thrombocytopenia of less than 100 X IO'/pL is overcome between 14 and 21 days after irradiation/reconstitution.
Recovery of the hematocrit was also correlated with the number of Thy-1.1''' Lin-Sca-l+ cells transplanted. A greater decrease in hematocrit was observed when only 100 Thy-1.1 ' " Lin-Sca-l + cells were transplanted. In these cases, the nadir occurred at day 14. In contrast, very few mice that received either 500 or 1,000 Thy-l. l'" Lin-Sca-l+ cells showed a decrease in the hematocrit to less than 30%.
The data from three independent experiments were combined in Fig 3. The kinetics of WBC recovery in these mice transplanted with different doses of HSCs did not differ significantly (Fig 3) . Although the levels of WBCs in hosts transplanted with 500 Thy-l .l'" Lin-Sca-l' cells were greater than hosts transplanted with 1 0 0 Thy-1.1'" Lin-Sca- On the other hand, the platelet counts at day 14 were directly correlated with the dose of Thy-1. l'" Lin-Sca-l+ 
-
cells transplanted (Fig 3) . At day 14, the platelet numbers were significantly different statistically between 100 cells and SO0 cells transplanted, as well as between 500 cells and 1.000 cells transplanted. However, the platelet counts by day 21 were similar with 100 cells or 500 cells transplanted, and even between I O cells and 1,000 cells transplanted.
The hematocrit nadir occurred at day 14. Although we observed statistically significant differences at that time in hematocrits for mice that received 100 Thy-1.1'" Lin-Sca-1 + cells versus 500 Thy-l . l ' " Lin-Sca-l+ cells, no difference was observed in hematocrits in the mice that received SO0 cells and 1,000 cells at day 14. The hematocrits of all groups were similar by day 21 and thereafter ( Fig 3) .
The ear!\, phase qf hematopoietic recovery afier transplantation qf Thv-1.1''' Lin-Sca-I' cells is donor-derived. To test whether Thy-1.1'" LinSca-l+ HSC transplantation led to donor-derived hematopoietic recovery in lethally irradiated mice, Ly-5 congenic marked B, myeloid, and T cells were examined in mice from experiment 1 on day 14 (Fig 4) . +. 12% and 65% f 30% of donor-B and myeloid cells, respectively, were detected in the blood of mice that received 100 Thy-1.1'" LinSca-l+ cells (n = 3); 60% 2 6% and 93% ? 3% in those that received 500 cells In = 31; and 61% f 4% and 92% f 1% in those that received 1,000 cells (n = 2). One of three mice transplanted with 100 cells did not contain detectable levels of B cells (A); however, at day 21, 98% ? 1.4% of donor B cells were detected in those that received 100 cells (n = 2). ND, not detectable level.
It was shown previously that 100 Thy-1.1'" Lin-Sca-l+ cells could radioprotect 95% to 100% of lethally irradiated mice." Although 3 of 3 mice tested receiving 100 Thy-1.1'" Lin-Sca-1 + cells contained donor-derived myeloid cells (65% of Mac-1 and Gr-l+ blood cells) on day 14 after transplantation, 1 of 3 mice did not contain donor-derived B cells at this time point (Fig 4A) . About 10% to 20% of PBLs were myeloid, and 293% of these were donor-derived in the mice transplanted with 500 Thy-1.1'" Lin-Sca-l+ cells (Fig 4B) . When 1,000 Thy-1.1'" Lin-Sca-l+ cells were transplanted, 20% to 30% of PBLs were myeloid and 294% of these were donor-derived (Fig 4C) . At 14 days, we detected not only myeloid but also B cells derived from the donor in animals receiving 1,000 cells ( Fig 4C) .
The mice studied in Figs 2 and 3 were kept alive to provide serial sampling intervals from each cohort. Unfortunately, at days 7 to 14 after irradiation and reconstitution it was difficult to obtain sufficient amounts of blood to evaluate WBCs, hematocrit, and platelets, as well as to stain for Ly-5 (donor versus host) markers of blood cell type without compromising their well-being or viability. Therefore, a cohort of mice reconstituted with 100 to 500 Thy-1.1'" LinSca-l+ BM cells was prepared to examine donor repopulation of the BM. A representative sample of BM from a mouse 9 days after lethal irradiation and injection with 200 Thy-1.1" Lin-Sca-1' cells is shown in Fig 5; greater than 95% of the Gr-l/Mac-1-positive cells were derived from the donor cells. A more extensive set of data is shown in Table 1 . On days 14, 21, and 28, 97% to 99% of cells in the BM were derived from 500 injected Thy-1.1'" Lin-Sca-I + cells. On day 7, 36% of the obtainable BM cells were donor-derived; the rest of the cells were probably host cells that are radioresistant at this assay interval (Aguila, Uchida, and Weissman, manuscript in preparation).
The long-term hematopoietic recove y after transplantation of Thy-1.1'" Lin-Sca-l+ cells is donor-derived. To test whether Thy-1 .l" Lin-Sca-l+ HSC transplantation led to long-term donor-derived multilineage reconstitution, PB cells were examined at 29 weeks after transplantation. Normal levels of B, myeloid, and T cells of donor origin were detected in the PB of lethally irradiated animals whether they had received 100 or 1,000 cells (Fig 6) . Virtually all B cells (298%) and myeloid cells (298%) were donor-derived in mice transplanted with 1,000 Thy-1.1'" Lin-Sca-l+ cells, whereas at this time point 59% of T cells were donor-derived. We detected endogenous T cells in the blood of mice transplanted with 1 X lo5 BM cells as well," presumably because a subset of T cells is radioresistant.3' Three of four mice transplanted with 100 Thy-1.1'" Lin-Sca-l+ cells were longterm reconstituted with donor-derived cells in multilineages. The low dose of irradiation received by these mice (7.8 Gy for experiment l), due to an x-ray machine calibration error, Long-term multilineage reconstitution by transplanting purified Thy-1.P Lin-Sea-l' cells. The recipient mice were transplanted with 100 (A) or 1,000 (B) Thy-1.1'" Lin-Sca-l' cells. PB cells were analyzed 29 t o 32 weeks after irradiationltransplantation. The percentages of Ly-5-marked B220+, Mac-l and Gr-l*, or Thy-l* cells originating from transplanted Thy-1.1" Lin-Sca-l' cells in a representative mouse are indicated in each panel. Three of four mice transplanted with 100 Thy-1.1" Lin-Sca-l' cells were reconstituted with long-term multilineage donor-derived cells. Averages of 91% f 6%. 55% ? 2496, and 35% f 11% of donor-derived B, myeloid, and T cells, respectively, were detected in the blood of mice that received 100 Thy-1.1'" Lin-Sca-l' cells (n = 3); 98% f 0.5%. 98% f 0.4%. and 59% t 11% donor cells in mice that received 1,000 cells (n = 2). 
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Not Done , as well as day-8 colony-forming units-spleen (CFU-S) and some day-l2 CFU-S.'x.32.33 It would be reasonable to assume that these progenitors may play a major role in the early phases of hematopoietic engraftment in BMT, because they are capable of differentiating to mature blood cells within a few days. Thy-l.l'"Lin-Sca-l' cells represent -0.05% of BM; 500 Thy-1.1'" Lin-Sca-l' cells would be calculated to be contained in 1 X IO" BM cells. Thus, we compared hematopoietic recovery with 500 Thy-l .l'" LinSca-l' and 1 X 10" transplanted BM cells (Fig 7) . Surprisingly, 1 X IOh BM cells, the mixture of mature and immature hematopoietic cells including -500 Thy-I . 10" BM, although in the third experiment it did (Fig 7) . The PB platelet counts in mice injected with 500 Thy-l .l'" LinSca-l'' cells was delayed only I to 4 days longer than those achieved by 1 X 10" BM cells. Mice receiving 1 X IO" BM cells sustained a hematocrit greater than 32%. similar to those receiving 500 Thy-I . 1 ' " Lin-Sca-I ' cells. Only a slight delay in hematocrit recovery was observed at day 14. Therefore, in these experiments, the early postirradiation recovery of WBCs (mainly myelomonocytic cells), platelets, and RBCs is comparable to that achieved with 2,000-fold more cells. FACS analyses (the qualitative data) from samples from transplanted mice are shown in Figs 10 through 13, and a semiquantitative assessment of all samples analyzed is presented in Table 3 .
FACS plots of the myelomonocytic cells from mice sacrificed at day 11 postirradiation and reconstitution are shown in Fig IO. The appearance of donor-derived myeloid cells is shown at day 11 (Fig lo) , although some mice did not have detectable levels of myeloid cells. More evident results were obtained at day 14 postirradiation in the myelomonocytic and B cells (Fig 1 I A and B) . wanes in comparison to that at day 14. Similar results for Gr-I/Mac-l and B220' cells are seen at day 29 (Fig 13A  and B) . In Fig 13C, in contrast The semiquantitative assessment of PB Gr-I/Mac-l-and B220-positive cells and their donor progenitor sources are presented in Table 3 . Two hundred Thy-l . l'" Lin-Sca-I + cells alone or in competition are a major source of Gr-l/ Mac-l-positive cells at all assay intervals (IO, 14, 21, and 29 days) and contribute significantly to B cells on day 21 and thereafter. Unfractionated BM cells (4 X IO5) give rise to both Gr-I/Mac-I -and B220-positive cells at the earliest time they can be detected. Sca-l -cells (4 X IO') are poor myelomonocytic progenitors, but contain significant but short-term B-cell reconstitutive activity.
Within the Thy-]. I"' Lin-Sca-l' population, the Rh123"' subset preferentially contributes to the ear1.y appearance of rnyelornonocytic progenv. The long-term repopulation capacity of whole BM or of enriched HSC-containing subsets appears to be concentrated in the 2% to S% of BM cells that largely exclude Rh123 from mitochondrial staining (Rh123'"),''.3s whereas Rh123"' cells appear to be more enriched in short-term but not in long-term in vivo double transfer reconstitution type assays (pre-CFU-S assay).'2 To assess directly whether the Gr-I/Mac-l reconstitution patterns seen with Thy-l .l'" Lin-Sca-l'' cells is also divisible along these lines, the congenic mouse lines were used for competitive reconstitution using S0 Rh123'" versus 200 . , , , , , I I . ,,,,,, . . .,....,I . . .,.,., . . . , .., . .,...I . . .,...,I . . . , 1 ' I ' I Cellularity of BM. To identify early foci of hematopoiesis generated by Thy-1.1'" Lin-Sca-l' HSCs, BM sections were evaluated (Fig 15) 7 days after irradiation/reconstitution. When the irradiated mice did not receive cells, we did not observe any foci of hematopoiesis throughout the BM sections (Fig 15A) . After the injection of 100, 500, or 1,000 Thy-1.1 Io Lin-Sca-1 + cells, distinct foci of hematopoiesis in the bone marrow could be detected at 7 days, mainly in proximity to the endosteum (Fig 15B) . These foci were predominantly myeloid (Fig 13C) , whereas some "pure" megakaryocytic colonies were also found, usually at some distance from the endosteum (Fig 15D) .
DISCUSSION
Although it is clear that the critical cell population for long-term repopulation of the hematolymphoid system in
BMT are HSCs, it has been reasonable to assume (and in fact is part of the conventional wisdom) that other hematopoietic progenitors, and even immediate precursors of blood cells, are the major contributors to the early phases of hematopoietic recovery. Until progenitor and more mature cells could be separated from HSCs, it was impossible to test this conventional wisdom, and therefore impossible to determine the extent to which stem cells contribute to early hematopoietic recovery as well as long-term marrow reconstitution. We have defined HSCs as cells that are each capable of differentiation to all blood cells and elements (multilineage differentiation) and self-renewal. Thy-l .l1" Lin-Sca-I ' cells (but no other cells in CS7BL/Ka-Thyl. 1 BM) are highly enriched for and perhaps entirely composed of HSCs. Thy-I. 1 I'' LinSca-l' cells are biologically heterogeneous at the singlecell level; one example is how long each clone sustains
For hematopoiesis (and presumably self-renewal) in vivo'9.23,36,37 (Uchida and Weissman, manuscript in preparation, and Morrison and Weissman, manuscript in preparation). Myelomonocytic cells (Mac-l/Gr-l+) are short-lived in vivo. B and T cells can undergo extensive amplification and generation of long-term memory cells in response to antigenic stimulation. Therefore, we believe that the assessment of Mac-l/ Gr-l-positive cells in the blood is most sensitive for the early and sustained activity of progenitors.
In this report, we present evidence that the early phase (7 to 21 days) and middle phase (21 to 35 days) of hematopoietic recovery in lethally irradiated mice can be achieved exclusively through the proliferation and differentiation of purified Thy-1.1"' Lin-Sca-l+ HSCs. The minimum number of Thy-1.1'' Lin-Sca-l+ stem cells required to radioprotect 95% to 100% of animals (PDg5) is 100 cells. weeks. Increasing the dose of Thy-l. l'" Lin-Sca-l+ stem cells to 500 cells led to a more rapid recovery of all cell types tested, but provision of 1,000 such cells was not significantly more proficient in a quantitative or kinetic sense for the production of WBCs and RBCs (Fig 3) . Thy-1.1'" Lin-Sca-l' cells represent about 0.05% of whole BM,'* and therefore 1 X IO6 BM cells should contain on the order of 500 Thy-1.1'" Lin-Sca-l' cells. When 1 X IO" BM cells were compared with 500 Thy-1.1'" Lin-Sca-l' cells in lethally irradiated mice, there was only a minor delay in the appearance of platelets and increase in hematocrit (1 to 3 days) at day 14 when HSCs are used, and no kinetic difference for the early increase of WBCs (mainly myelomonocytic cells), although in these experiments BM cells eventually gave rise in the mid-term (days 21 to 28 in 2 of 3 is impossible to determine whether the thrombocytopenia observed resulted from a defect in the Lin-Sca-l+ population, the high-dose irradiation protocol (650 R X 2 v 425 R X 2 or 440 R X 2 protocols used here), or both. The doses of irradiation used in the experiments described here were fully lethal and excluded host nucleated blood reconstitution over the period assayed, except for T cells. At the time of our experiments, a dose of 650 R X 2 led to death by a radiation syndrome that could not be protected by BM cell injection. The Bradford et al"* study could point to a potential serious problem with supralethal doses of irradiation, and it will be of interest to learn whether the thrombocytopenia they observe is present in mice receiving doses of unfractionated BM cells that contain -1, OOO Lin-Sca-l+ BM cells. If so, perhaps host elements critical for thrombopoiesis are selectively radiosensitive in the 8.5 to 13.0 Gy (850 to 1,300 R) range.
In contrast to Thy-l .l" Lin-Sca-l + HSCs, the -96% of BM that is Sca-l-lacks significant progenitors, as measured by generation of myelomonocytic cells. However, Sca-lcells do contain short-term B-lineage progenitors. Taken together, these observations quite clearly indicate a major role for stem cells (as a population) in both early and late hematopoietic recovery, and do not provide strong evidence for a major role by committed progenitors in the early phases of hematopoietic recovery. These observations are consistent with data from a previous study in which irradiated mice PBlood samples from transplanted animals were harvested and processed as described in the Materials and Methods. Cells were stained for antibodies against Ly-5.1, Ly-5.2, and Mac-VGr-l, and FACS results were shown in Fig 9 (day 11). Fig 10A (day 14) . Fig 11A (day 21) . and Fig  12A (day 29) . To confirm low levels of Sca-I--derived (donor B) Mac-1/Gr-l' cells, Ly-5.1+ (either donor) cells were plotted against Mac-I/Gr-1 and Ly-5.2 in logarithmic plots. For example, in Fig 9, the 5 donor A plots (row 1, panel 2: row 2, all 4 panels) show 0.4% to 2.1% of the signals from Ly-5.1 only cells in the Ly-5.2 "box." Two samples in row 4 (panels 2 and 4) fell within that range and were designated negative, and two (panels 1 and 3) were above that range but clearly quite different from the Ly-5.1' Ly-5.2-"box," and were designated low. Only an evident Ly-5.1' Ly-5.2+ and Mac-VGr-l' population was scored as a positive.
received 2 X lo5 non-HSCs, either Thy-l.l-, Sca-l-, or Lin' BM cells; together, these cells represent 99.95% of BM cells, yet irradiated hosts receiving them survived 5 6 days longer than mice receiving no cells?' In that study, both 4 X lo4 Sca-l-and Lin' BM cells contain relatively shortlived B-lineage progenitors, whereas 2 X l O5 Thy-1.1 -cells included progenitors for B-lineage cells for at least 14 weeks2' The relatively short lifespan of B-lineage cells derived from Sca-l-progenitors may make them valuable to develop in vivo assays to study the effect of antigens a n d or other agents on selection, outgrowth, and longevity of cells of the B lineage.
The enhanced production of WBCs and, to some extent, platelets at 21 and 28 days postreconstitution in mice receiving 1 X lo6 BM cells as compared with 500 Thy-1.1" LinSca-l+ cells in two of three experiments could deserve further investigation. Perhaps another class of cells in the BM is involved in this second phase of recovery, eg, BM T cells producing hematopoietic cytokines; or perhaps engraftment of more lineage-committed progenitors results in a 14-to 21-day lag before their contribution to WBCs is apparent.
Spangrude and Johnson22 showed that Thy-l .l'' Lin-Scal + cells can be further subdivided into rhodamine-l23 low and high (Rh-123Io, Rh-123hi) subsets. IU1-123~' Thy-1.1'' Lin-Sca-l+ cells were highly enriched for day-l3 CFU-S activity, but were not correspondingly enriched for pre-CFU-S or hematopoietic repopulation activity when the experimental circumstance was early (13 days) secondary transfer into lethally irradiated mice?' The Rh-123'" Thy-1.1' ' ' Lin-Sca-l+ subset was most highly enriched for pre-CFU-S and hematopoietic repopulation a~t i v i t y .~~,~~ We show here that the early phase of hematopoietic engraftment is mainly achieved by the Rh-123hi Thy-1.1'" Lin-Sca-l+ subset, whereas the Rh-123'" Thy-1.1'" Lin-Sca-1' subset contributes more substantially to mid-phase multilineage reconstitution. Moreover, the compartment of Thy-1.1'" LinSca-l+ cells are clearly heterogeneous in terms of repopulation kinetics and sustained hematopoietic potential, a well as for a number of other ~arameters.".~~.~~ Elsewhere, we report that phenotypic markers can define within the Thy-1 .l" Lin-Sca-l+ population subsets highly enriched for early versus mid versus sustained hematopoiesis (Morrison et al, manuscript in preparation). The biologic bases for these differences are not yet known, nor is the lineage relationship between these subsets.
That is not to say that hematopoietic progenitors cannot also contribute to early and late hematopoiesis. Thy-1.1-cells, Lin+ cells, and Sca-l-cells can all contribute substantially to B lymphocytopoiesis.*' Still, it is likely that the most important blood elements in the early phases of hematopoietic recovery are myeloid, and/or platelets, and/or erythrocytes to protect the hosts from infection, bleeding, and anemia, respectively. Perhaps the repopulation ability of non-HSC progenitor cells in vivo may not be sufficient to contribute significant levels of blood elements during the early phases of hematopoietic recovery, because they can only undergo a limited number of cell divisions; or perhaps they are less efficient at seeding hematopoietic microenvironments than HSCs.
In these studies, the majority of early and late hematopoiesis that is donor-derived after BMT appears to be caused by the HSC content of the BM inoculum. This finding raises several questions. For example, do the HSCs home preferentially to BM and land in self-renewal microenvironments in For
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a BMT situation, in contrast to other committed hematolymphoid progenitors? Or is it likely that committed progenitors have a sufficiently limited number of cell divisions they can undergo that they simply cannot provide the major outcome of hematopoiesis that HSCs provide? Another possibility is that the frequency of HSCs that enter the proliferative and differentiative cycle is dependent on the frequency and state of differentiation of other non-stem cells in the BM or the blood, so that the provision of large numbers of hematopoietic progenitors suppresses early cell divisions by hematopoietic stem cells, even in the lethally irradiated host. It shall be interesting to determine the fraction of HSCs that enter the mitotic cycle in lethally irradiated animals in the presence or absence of added hematopoietic progenitors and more mature BM cells. 
